Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Pastor

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|March 13, 2014
Idiotype vaccine production using hybridoma technologySusana Inoges, Ascensión López Díaz de Cerio, Helena Villanueva, et al.
Pharmaceuticals (Basel, Switzerland)|October 21, 2018
Aptamer-iRNAs as Therapeutics for Cancer TreatmentMario M Soldevilla, Daniel Meraviglia-Crivelli de Caso, Ashwathi P Menon, et al.
Microbes and Infection|September 4, 2004
Lipopolysaccharide needs soluble CD14 to interact with TLR4 in human monocytes depleted of membrane CD14Cristina Moreno, Juana Merino, Natalia Ramírez, et al.
Oncotarget|December 20, 2015
Identification of TIM3 2'-fluoro oligonucleotide aptamer by HT-SELEX for cancer immunotherapySandra Hervas-Stubbs, Mario M Soldevilla, Helena Villanueva, et al.
Nature Reviews. Drug Discovery|September 8, 2018
An RNA toolbox for cancer immunotherapyFernando Pastor, Pedro Berraondo, Iñaki Etxeberria, et al.
Molecular Therapy. Nucleic Acids|October 19, 2016
In Silico Aptamer Docking Studies: From a Retrospective Validation to a Prospective Case Study-TIM3 Aptamers BindingObdulia Rabal, Fernando Pastor, Helena Villanueva, et al.
ACS Nano|November 16, 2023
Engineering U1-Based Tetracycline-Inducible Riboswitches to Control Gene Expression in MammalsEric Rovira, Beatriz Moreno, Nerea Razquin, et al.
World Journal of Clinical Oncology|July 21, 2011
Idiotype vaccines for lymphoma: Potential factors predicting the induction of immune responsesSusana Inoges, Ascension Lopez-Diaz de Cerio, Helena Villanueva, et al.
Expert Review of Vaccines|June 23, 2011
Idiotype vaccines for lymphoma therapySusana Inogés, Ascensión López-Díaz de Cerio, Helena Villanueva, et al.
Methods in Cell Biology|February 22, 2026
Metastasis mouse model of breast cancer derived from circulating tumor cells (CTCs) after primary orthotopic tumor resectionÁngela Pérez-Cervera, Haritz Moreno, Helena Villanueva, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Methods in Molecular Biology (Clifton, N.J.)|March 13, 2014
Idiotype vaccine production using hybridoma technologySusana Inoges, Ascensión López Díaz de Cerio, Helena Villanueva, et al.
Pharmaceuticals (Basel, Switzerland)|October 21, 2018
Aptamer-iRNAs as Therapeutics for Cancer TreatmentMario M Soldevilla, Daniel Meraviglia-Crivelli de Caso, Ashwathi P Menon, et al.
Microbes and Infection|September 4, 2004
Lipopolysaccharide needs soluble CD14 to interact with TLR4 in human monocytes depleted of membrane CD14Cristina Moreno, Juana Merino, Natalia Ramírez, et al.
Oncotarget|December 20, 2015
Identification of TIM3 2'-fluoro oligonucleotide aptamer by HT-SELEX for cancer immunotherapySandra Hervas-Stubbs, Mario M Soldevilla, Helena Villanueva, et al.
Nature Reviews. Drug Discovery|September 8, 2018
An RNA toolbox for cancer immunotherapyFernando Pastor, Pedro Berraondo, Iñaki Etxeberria, et al.
Molecular Therapy. Nucleic Acids|October 19, 2016
In Silico Aptamer Docking Studies: From a Retrospective Validation to a Prospective Case Study-TIM3 Aptamers BindingObdulia Rabal, Fernando Pastor, Helena Villanueva, et al.
ACS Nano|November 16, 2023
Engineering U1-Based Tetracycline-Inducible Riboswitches to Control Gene Expression in MammalsEric Rovira, Beatriz Moreno, Nerea Razquin, et al.
World Journal of Clinical Oncology|July 21, 2011
Idiotype vaccines for lymphoma: Potential factors predicting the induction of immune responsesSusana Inoges, Ascension Lopez-Diaz de Cerio, Helena Villanueva, et al.
Expert Review of Vaccines|June 23, 2011
Idiotype vaccines for lymphoma therapySusana Inogés, Ascensión López-Díaz de Cerio, Helena Villanueva, et al.
Methods in Cell Biology|February 22, 2026
Metastasis mouse model of breast cancer derived from circulating tumor cells (CTCs) after primary orthotopic tumor resectionÁngela Pérez-Cervera, Haritz Moreno, Helena Villanueva, et al.
Pageof 6